Lipid Nanoparticle Delivery in COVID-19 mRNA Vaccines: Immune Mechanisms, Manufacturing Processes, and Future Perspectives
Explore Medical Science and Global Health · 21.07.2026 · 3 · 1-6
DOI: 10.70267/emsgh.2603.0106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Explore Medical Science and Global Health, online erschienen am 21.07.2026. Verfasst von Mingjun Zou. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The COVID-19 mRNA vaccine is one of the most successful examples of nucleic acid vaccine technology. Rather than directly injecting the viral protein itself, this technology introduces an RNA sequence that encodes the COVID-19 virus’s spike protein into human cells. This causes the cells to temporarily produce the antigen, thereby training the immune system to recognize the virus. Since mRNA itself is easily degraded and cannot enter cells on its own, lipid nanoparticles serve as a reliable delivery system for mRNA vaccines. These lipid nanoparticles help to maintain the stability of the mRNA within the body and facilitating its uptake by cells. This article examines the use of lipid nanoparticles for delivery in COVID-19 mRNA vaccines, summarizing their basic composition, the antigen expression process following cellular uptake, the mechanisms of immune activation, large-scale production processes, and their characteristics when compared to conventional inactivated vaccines. Finally, this article discusses the potential for future improvements to this technology in terms of stability, ease of transport, rapid adaptation to viral variants, and broader vaccine development.
Zitieren
APA
Zou, M. (2026). Lipid Nanoparticle Delivery in COVID-19 mRNA Vaccines: Immune Mechanisms, Manufacturing Processes, and Future Perspectives. Explore Medical Science and Global Health, 3, 1-6. https://doi.org/10.70267/emsgh.2603.0106
Vancouver
Zou M. Lipid Nanoparticle Delivery in COVID-19 mRNA Vaccines: Immune Mechanisms, Manufacturing Processes, and Future Perspectives. Explore Medical Science and Global Health. 2026;3:1-6. doi:10.70267/emsgh.2603.0106
BibTeX
@article{Zou2026,
author = {Zou, Mingjun},
title = {Lipid Nanoparticle Delivery in COVID-19 mRNA Vaccines: Immune Mechanisms, Manufacturing Processes, and Future Perspectives},
journal = {Explore Medical Science and Global Health},
year = {2026},
volume = {3},
pages = {1--6},
doi = {10.70267/emsgh.2603.0106}
}
EUVIMED